-
A
Placebo-Controlled Study of Study Drug and Paroxetine in Patients
with Panic Disorder
- Open-Label
Safety Study of Study Drug Patients with Anxiety Disorders
-
A
Double-Blind, Placebo-Controlled, 3-Arm Fixed Dose Study of
Study Drug Continuous Treatment for Premenstrual Dysphoric Disorder
-
A
3-Month, Double-Blind, Placebo-Controlled, Fixed-Dose Extension
Study of Study Drug (12.5 mg and 25 mg/day) Continuous Treatment for PMDD Patients Completing
Studies X, Y and Z
-
Study
Drug, Placebo, and Paroxetine Comparison in Patients with Major
Depressive Disorder
-
Open-label
Study Drug Continuation Therapy (Major Depressive Disorder)
-
A
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
of Study Drug in the Maintenance Treatment of Patients with Bipolar Disorder
-
A
Placebo-Controlled Study of Study Drug Dosed BID and TID in
Patients with Generalized Anxiety Disorder
-
A
Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate
the Safety and Efficacy of Study Drug Therapy for Agitation in Nursing Home Residents with
Probable or Possible Alzheimer's Disease
-
Placebo-Controlled
Study Drug Monotherapy in the Treatment of Bipolar I Depression
-
Switching
Subjects from Citalopram, Paroxetine or Sertaline to Once-Weekly
Modified-Release Study Drug in the Maintenance of Response for Depression
-
Continuation
Treatment with Once-Weekly Modified-Release Study Drug (Depression)
-
A
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
of Three Fixed Doses of Study Drug in the Treatment of Institutionalized Patients with
Psychosis Associated with Dementia of the Alzheimer's Type
-
A
Double-Blind, Placebo-Controlled Study of Study Drug in the
Treatment of Behavioral Agitation in Elderly Patients with Dementia
